-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The net result for the period of deducting operating expenses from operating revenues.
-
Summary
-
Nuvectis Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2021 to Q3 2024.
- Nuvectis Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$4.36M, a 29.2% increase year-over-year.
- Nuvectis Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$20.3M, a 11.2% increase year-over-year.
- Nuvectis Pharma, Inc. annual Operating Income (Loss) for 2023 was -$22.9M, a 19% decline from 2022.
- Nuvectis Pharma, Inc. annual Operating Income (Loss) for 2022 was -$19.2M, a 49.2% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)